Ming-Chun Hsu
Impact in
- Dermatology top 0.5%
- Dermatology and Skin Diseases
- Immunology top 1%
- Psoriasis: Treatment and Pathogenesis
- Immunodeficiency and Autoimmune Disorders
Papers in
- Immunology 14
- Psoriasis: Treatment and Pathogenesis 14
- Immunodeficiency and Autoimmune Disorders 2
-
- Pharmaceutical studies and practices 5
- Co-authors
- Richard G. Langley (7 shared papers)Kristian Reich (7 shared papers)Philippe Szapary (3 shared papers)Gerald G. Krueger (2 shared papers)Mark Lebwohl (2 shared papers)Newman Yeilding (2 shared papers)Kim Papp (2 shared papers)Cynthia Guzzo (2 shared papers)
- Journals
- Journal of the American Academy of Dermatology (3 papers)The Lancet (2 papers)British Journal of Dermatology (2 papers)Lara D. Veeken (1 paper)Journal of Dermatological Treatment (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Ming-Chun Hsu
14 papers receiving 1.7k citations
Ming-Chun Hsu's Hit Papers
Peers
Comparison fields: 5 of 71
- Dermatology 824
- Immunology 1.5k
- Rheumatology 323
- Hematology 232
- Pathology and Forensic Medicine 281
Countries citing papers authored by Ming-Chun Hsu
This map shows the geographic impact of Ming-Chun Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Chun Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Chun Hsu more than expected).
Fields of papers citing papers by Ming-Chun Hsu
This network shows the impact of papers produced by Ming-Chun Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Chun Hsu. The network helps show where Ming-Chun Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming-Chun Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) Hit paper breakdown → | 2008 | 1067 |
| 2 | 2019 | 259 | |
| 3 | 2014 | 141 | |
| 4 | 2011 | 103 | |
| 5 | Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use. | 2013 | 51 |
| 6 | 2017 | 45 | |
| 7 | 2021 | 21 | |
| 8 | 2018 | 17 | |
| 9 | Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations. | 2008 | 15 |
| 10 | 2020 | 3 | |
| 11 | 2025 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 1 |
About Ming-Chun Hsu
Ming-Chun Hsu is a scholar working on Immunology, Pediatrics, Perinatology and Child Health, Pathology and Forensic Medicine, Dermatology and Physiology, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (14 papers), Pharmaceutical studies and practices (5 papers), Autoimmune Bullous Skin Diseases (4 papers), Asthma and respiratory diseases (3 papers), Dermatology and Skin Diseases (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Spondyloarthritis Studies and Treatments (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). The work is most often cited by research in Dermatology (824 citations), Immunology (1.5k citations), Rheumatology (323 citations), Hematology (232 citations) and Pathology and Forensic Medicine (281 citations). Ming-Chun Hsu has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Richard G. Langley, Kristian Reich, Philippe Szapary, Gerald G. Krueger, Mark Lebwohl, Newman Yeilding, Kim Papp, Cynthia Guzzo, Shu Li and Lisa T. Dooley. Their work appears in journals such as Journal of the American Academy of Dermatology, The Lancet, British Journal of Dermatology, Lara D. Veeken and Journal of Dermatological Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.